Systemic mast cell disease (SMCD) and bone pain - A case treated with radiotherapy

被引:4
|
作者
Hesselmann, S [1 ]
Micke, O [1 ]
Schaefer, U [1 ]
Willich, N [1 ]
机构
[1] Univ Hosp Muenster, Dept Radiotherapy & Radiooncol, Munster, Germany
关键词
systemic mast cell disease; SMCD; bone pain; radiotherapy;
D O I
10.1007/s00066-002-0928-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Systemic mast cell disease (SMCD) is a rare disease characterized by a multitopic proliferation of cytologically and/or functionally abnormal tissue mast cells. SMCD preferentially involves the skin, spleen, Liver, lymph nodes and the bone marrow. The cause of SMCD is unknown. Bony pain, caused by mast cell infiltration of the marrow cavity, is present in up to 28% of cases and is frequently chronic and difficult to palliate with medical therapy. Case Report: We report one case of refractory bone pain in a 54-year-old female Caucasian patient with advanced SMCD and associated bony involvement, which was treated with radiotherapy for pain palliation. Between 1995 and 1998, the patient was irradiated at four different locations: 1) right shoulder and proximal right humerus, 2) both hands, 3) both knees, 4) left humerus with a total dose of 40 Gy in 2.0 or 2.5 Gy daily fractions. Results: Different results of pain palliation were achieved. In one location the pain was reduced for 55 months until her death due to disease progression, whereas in two other Locations a pain control was maintained for 3 and 6 months after radiotherapy. In one Location, no pain reduction was achieved. Severe side effects were not observed. Conclusion: Palliative radiotherapy has a role in the control of severe intractable bone pain in patients with advanced SMCD, though in some cases the effect may be short or incomplete. The observed palliation of pain can even differ in the same patient.
引用
收藏
页码:275 / 279
页数:5
相关论文
共 50 条
  • [41] Familial Occurrence of Systemic Mast Cell Activation Disease
    Molderings, Gerhard J.
    Haenisch, Britta
    Bogdanow, Manuela
    Fimmers, Rolf
    Noethen, Markus M.
    PLOS ONE, 2013, 8 (09):
  • [42] URTICARIA PIGMENTOSA AND SYSTEMIC MAST-CELL DISEASE
    TRAVIS, WD
    LI, CY
    SU, DW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1984, 82 (03) : 369 - 369
  • [43] HEPATIC INVOLVEMENT IN SYSTEMIC MAST-CELL DISEASE
    YAM, LT
    CHAN, CH
    LI, CY
    AMERICAN JOURNAL OF MEDICINE, 1986, 80 (05): : 819 - 826
  • [44] Imatinib therapy for systemic mast cell disease.
    Pardanani, A
    Reeder, T
    Elliott, M
    Li, CY
    Tefferi, A
    BLOOD, 2002, 100 (11) : 70A - 70A
  • [45] RADIOLOGICAL FEATURES OF SYSTEMIC MAST-CELL DISEASE
    HUANG, TY
    YAM, LT
    LI, CY
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (716): : 765 - 770
  • [46] Systemic mast cell disease: a rare cause of osteoporosis
    Cacace, E.
    Salis, G.
    Ruggiero, V.
    Perpignano, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (02) : 210 - 210
  • [47] Treatment of systemic mast-cell disease with cladribine
    Tefferi, A
    Li, CY
    Butterfield, JH
    Hoagland, HC
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (04): : 307 - 309
  • [48] SPLENECTOMY IN THE MANAGEMENT OF SYSTEMIC MAST-CELL DISEASE
    FRIEDMAN, B
    DARLING, G
    NORTON, J
    HAMBY, L
    METCALFE, D
    SURGERY, 1990, 107 (01) : 94 - 100
  • [49] SYSTEMIC MAST-CELL DISEASE WITH URTICARIA PIGMENTOSA
    REILLY, EB
    SHINTANI, J
    GOODMAN, J
    ARCHIVES OF DERMATOLOGY, 1955, 71 (05) : 561 - 569
  • [50] MALIGNANT SYSTEMIC MAST CELL DISEASE (MASTOCYTOMA) IN MAN
    BLOOM, G
    FRANZEN, S
    SIREN, M
    ACTA MEDICA SCANDINAVICA, 1960, 168 (02): : 95 - 102